Scarica l'app Stockscreener
30.51
1.58%
-0.49
Dopo l'orario di chiusura:
30.51
Precedente Chiudi:
$31.00
Aprire:
$31.97
Volume 24 ore:
1.13M
Relative Volume:
0.77
Capitalizzazione di mercato:
$1.95B
Reddito:
-
Utile/perdita netta:
$-107.85M
Rapporto P/E:
-13.81
EPS:
-2.21
Flusso di cassa netto:
$-106.82M
1 W Prestazione:
-0.07%
1M Prestazione:
+23.22%
6M Prestazione:
+43.64%
1 anno Prestazione:
-23.71%
Intervallo 1D:
$30.04
$31.97
Intervallo di 1 settimana:
$29.41
$31.97
Portata 52W:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Nome
Vera Therapeutics Inc
Settore
Industria
Telefono
650-770-0077
Indirizzo
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Confronta VERA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
30.51 | 1.93B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-16 | Iniziato | BofA Securities | Buy |
| 2025-08-04 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2025-01-28 | Iniziato | Goldman | Buy |
| 2024-11-21 | Iniziato | Wells Fargo | Overweight |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-01-25 | Iniziato | Oppenheimer | Outperform |
| 2024-01-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Iniziato | Raymond James | Outperform |
| 2023-11-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-16 | Iniziato | Guggenheim | Buy |
| 2023-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-01-04 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-07-12 | Iniziato | JP Morgan | Overweight |
| 2022-05-02 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-19 | Iniziato | Wedbush | Outperform |
Mostra tutto
Vera Therapeutics Inc Borsa (VERA) Ultime notizie
Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market - Benzinga
Vera Therapeutics Poised for Strong Upside on 'Rare' Autoimmune Drug Opportunity, BofA Says - MarketScreener
This Celestica Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Vera Therapeutics Gears Up For A Major Drug Launch - Finimize
Can Vera Therapeutics Inc. hit a new high this month2025 Top Gainers & Smart Swing Trading Techniques - newser.com
Ranking Vera Therapeutics Inc. among high performing stocks via tools - newser.com
Why Vera Therapeutics Inc. stock could rally in 20252025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
Real time alert setup for Vera Therapeutics Inc. performanceTake Profit & Growth Focused Stock Pick Reports - newser.com
Vera Therapeutics, Inc. (VERA): Investor Outlook on a 109% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
Will Vera Therapeutics Inc. stock remain a Wall Street favoriteGold Moves & Weekly Top Gainers Alerts - newser.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
Is Vera Therapeutics Inc. stock overvalued by current metricsJuly 2025 Levels & Reliable Breakout Forecasts - newser.com
Vera Therapeutics Inc. stock trend forecastCPI Data & High Return Stock Watch Alerts - newser.com
Is Vera Therapeutics Inc a good long term investmentBear Market Strategies & Follow Top Performers in the Community - earlytimes.in
Vera started at buy by Goldman Sachs, atacicept potential cited - MSN
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
135,100 Options: Vera Therapeutics Grants Inducement Awards Including 70,775 RSUs to 21 Hires - Stock Titan
Trend analysis for Vera Therapeutics Inc. this weekTrade Risk Report & Community Consensus Stock Picks - newser.com
Detecting support and resistance levels for Vera Therapeutics Inc.2025 Dividend Review & Fast Entry Momentum Alerts - newser.com
Vera Therapeutics' (VERA) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy - openPR.com
What indicators show strength in Vera Therapeutics Inc.Portfolio Gains Summary & Technical Pattern Alert System - newser.com
Using RSI to spot recovery in Vera Therapeutics Inc.2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Heatmap analysis for Vera Therapeutics Inc. and competitorsBear Alert & AI Powered Buy and Sell Recommendations - newser.com
Risk vs reward if holding onto Vera Therapeutics Inc.2025 Top Gainers & High Accuracy Swing Trade Signals - newser.com
J. Safra Sarasin Holding AG Takes Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Evaluating Vera Therapeutics Inc. with trendline analysisJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Developing predictive dashboards with Vera Therapeutics Inc. dataJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com
What drives Vera Therapeutics Inc stock priceLong-Term Growth Stocks & These Stocks Are Just Getting Started - earlytimes.in
Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $75 - 富途牛牛
Vera Therapeutics, Inc. $VERA Shares Purchased by Platinum Investment Management Ltd. - MarketBeat
13,567 Shares in Vera Therapeutics, Inc. $VERA Acquired by GC Wealth Management RIA LLC - MarketBeat
Fifth Third Bancorp Buys New Stake in Vera Therapeutics, Inc. $VERA - Defense World
10,406 Shares in Vera Therapeutics, Inc. $VERA Purchased by Perigon Wealth Management LLC - MarketBeat
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating - 富途牛牛
Vera Therapeutics Inc Azioni (VERA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Vera Therapeutics Inc Azioni (VERA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):